Hormazd Minwalla, DO
Psychiatry · Plano, TXNPI 1578060638
Payments from drug & device makers
Across 265 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$884
- Teva Pharmaceuticals USA, Inc.$749
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$602
- Corium, LLC$509
- AbbVie$424
- Johnson & Johnson$269
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,38698%
- Education$1112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 50 | $884 |
| Teva Pharmaceuticals USA, Inc. | 29 | $749 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $602 |
| Corium, LLC | 21 | $509 |
| AbbVie | 28 | $424 |
| Johnson & Johnson | 16 | $269 |
| Neurocrine Biosciences, Inc. | 6 | $269 |
| Alkermes, Inc. | 6 | $233 |
| E.r. Squibb & Sons, L.L.C. | 7 | $226 |
| Tris Pharma Inc | 6 | $218 |
| Noven Therapeutics, LLC | 12 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $191 |
| Idorsia Pharmaceuticals US Inc | 11 | $157 |
| Lundbeck LLC | 8 | $146 |
| Axsome Therapeutics, Inc. | 6 | $136 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Neos Therapeutics, LP | 3 | $54 |
| Merck | 2 | $42 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Itamar Medical Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$480
- Dyanavel XR$125
- Quillivant$125
- Quillichew ER$125
- INGREZZA$125
- ARISTADA INITIO$120
- AUSTEDO$105
- COBENFY$104
How this compares
$5,498 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 36 | $1,413 |
| Bupropion XlBupropion Hcl | 29 | $662 |
| Mirtazapine | 32 | $602 |
| Buspirone Hcl | 24 | $448 |
| Gabapentin | 28 | $408 |
| Trazodone Hcl | 33 | $253 |
| Zolpidem Tartrate | 20 | $247 |
| Lamotrigine | 21 | $207 |
| Hydroxyzine Hcl | 11 | $165 |
| Sertraline Hcl | 20 | $143 |
| Fluoxetine Hcl | 31 | $113 |
| Escitalopram Oxalate | 14 | $80 |
| Clonazepam | 13 | $75 |
| Alprazolam | 25 | $33 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Plano
- Suresh SureddiPlano$5.9M
- Sejal MehtaPlano$3.3M
- David CrumpackerPlano$386K
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.